Sporimune, a new treatment to tackle atopic dermatitis in dogs, is being launched by Dechra Veterinary Products in the UK.

Sporimune is available in packs containing a 25ml, 50ml or 100ml bottle, syringe and adaptor cap.

The easy-dispensing, flexible-dosing ciclosporin is licensed for the treatment of chronic manifestations of atopic dermatitis. It is the latest product unveiled as part of Dechra’s campaign to support vets in general practice who regularly see significant numbers of dogs with dermatological problems.

Sporimune is a 50 mg/ml oral solution administered by syringe, which is graduated to show both bodyweight and ml. It is being introduced to veterinary professionals within Dechra’s “Partners in Practice” programme, which aims to support vets and vet nurses as they diagnose, control and maintain complex dermatological conditions.

Roger Brown, senior brand manager at Dechra, said: “It is critical that owners are fully involved and educated about their pet’s condition for dogs to be treated effectively, so we have also developed support materials around the use of Sporimune for practices, including client information leaflets and a video on how to use the dosing syringe.”

Sporimune is now available from veterinary wholesalers in packs containing a 25ml, 50ml or 100ml bottle, syringe and adaptor cap. 

View your activity >

Leave a Reply

Be the First to Comment!

Notify of